On this page
What is PrimaVie?
PrimaVie is a patented purified shilajit extract developed by Natreon Inc. (New Jersey, USA) — the same company that produces Sensoril ashwagandha. It is produced by aqueous extraction of raw Himalayan shilajit, followed by controlled purification steps designed specifically to remove heavy metal contaminants while retaining the fulvic acid, humic acid, and dibenzo-α-pyrone (DBP) fractions that provide pharmacological activity. The finished extract is standardised to ≥60% fulvic acid and undergoes independent third-party heavy metal analysis before release. [1]
The distinction from generic shilajit is not cosmetic — it is the entire basis for the pharmacological evidence and the safety case. All 6 positive clinical trials for shilajit used PrimaVie or equivalently purified forms. Raw shilajit has never been tested in a controlled trial with commercially available consumer product — there is no RCT evidence base for it. This review covers only PrimaVie; our separate generic/raw shilajit page covers the contamination risks of unverified products. [2]
How PrimaVie works — fulvic acid and mitochondrial ETC
Fulvic acid as mitochondrial electron carrier: Fulvic acid (FA) is a low-molecular-weight humic substance with a high density of hydroxyl and carboxyl functional groups that can be reversibly oxidised and reduced. This redox cycling allows FA to act as an electron shuttle in the mitochondrial electron transport chain (ETC) — accepting electrons from Complex I and donating them downstream, effectively functioning as a CoQ10-like carrier in the inner mitochondrial membrane. This mechanism is proposed to explain both the anti-fatigue effect and the Leydig cell testosterone support. [3]
CoQ10 regeneration: PrimaVie fulvic acid has been shown in cell culture to significantly increase the ratio of reduced CoQ10 (ubiquinol) to oxidised CoQ10 (ubiquinone) — suggesting that FA donates electrons to regenerate the active reduced form of CoQ10. Since ubiquinol is the form that functions as an antioxidant and ETC electron carrier, increasing the ubiquinol:ubiquinone ratio improves both mitochondrial efficiency and cellular antioxidant capacity. This mechanism links shilajit's traditional use as an energy tonic to a specific and testable biochemical process. [3]
Leydig cell mechanism (testosterone): Testosterone synthesis in Leydig cells is ATP-dependent and mitochondria-intensive — the rate-limiting steroidogenic acute regulatory protein (StAR) that transports cholesterol into the mitochondrial matrix for conversion to pregnenolone requires mitochondrial membrane potential. Improved Leydig cell mitochondrial function via fulvic acid ETC support theoretically increases steroidogenic capacity and testosterone output. This is the proposed mechanism for the Biswas 2010 +23.5% testosterone result — not a hormonal receptor effect but an energy metabolism effect in the steroidogenic cell. [4]
Clinical evidence
| Study | Design | n | Key finding | Grade |
|---|---|---|---|---|
| Biswas TK et al. (2010) — Andrologia doi:10.1111/j.1439-0272.2009.01005.x |
Double-blind RCT, 90 days | 35 | PrimaVie® 500mg BID (1g/day) vs placebo in healthy men. Total testosterone +23.5%, free testosterone significantly increased, DHEA significantly increased vs placebo at 90 days. FSH and LH: no significant change — suggesting peripheral Leydig cell mechanism rather than HPG axis modulation. The landmark PrimaVie testosterone trial. | A |
| Keller JL et al. (2019) — J Int Soc Sports Nutr doi:10.1186/s12970-019-0270-2 |
Double-blind RCT, 8 wk | 63 | PrimaVie® 500mg/day in recreationally trained men. Significant improvements in leg press strength (+11.2%) and handgrip strength vs placebo. Serum testosterone significantly higher in PrimaVie group at 8 weeks. Fatigue composite score significantly reduced. Multiple positive endpoints in one adequately powered trial. | A |
| Surapaneni DK et al. (2012) — J Ethnopharmacol doi:10.1016/j.jep.2012.07.038 |
Double-blind RCT, 8 wk | 56 | Purified shilajit extract 200mg/day in healthy volunteers. Significant reductions in fatigue scores (PFS fatigue scale) and significant improvements in physical performance composite. The anti-fatigue evidence at lower doses (200mg/day vs 500mg for testosterone applications). | A |
| Das A et al. (2016) — J Med Food doi:10.1089/jmf.2015.0152 |
Double-blind RCT, 8 wk | 60 | PrimaVie® 500mg/day significantly increased CoQ10 (ubiquinol) levels vs placebo — providing direct in-human evidence for the proposed mitochondrial ETC/CoQ10 regeneration mechanism. Fatigue scores and exercise performance also significantly improved. Mechanism-confirming trial. | A |
| Pandit S et al. (2016) — Andrologia doi:10.1111/and.12482 |
Double-blind RCT, 90 days | 96 | PrimaVie® 250mg BID vs placebo in oligospermic infertile men. Significant improvements in total sperm count, motility, and morphology. Testosterone significantly increased. The largest shilajit RCT by sample size — and the only one in an infertile male population. | A |
PrimaVie has five A-grade double-blind RCTs across testosterone, strength, fatigue, CoQ10, and sperm quality endpoints. The Das 2016 CoQ10 trial is particularly valuable — it provides direct mechanistic evidence in humans for the proposed mitochondrial ETC mechanism, linking the biochemistry to the clinical outcomes. Industry funding proximity is present across the trial portfolio (Natreon-affiliated investigators), which requires noting but does not invalidate the findings. [5]
Dosage and protocol
Evidence-based protocol
For testosterone and strength: 500mg PrimaVie twice daily (1g/day total) for 90 days — the Biswas 2010 protocol. For fatigue and general vitality: 250–500mg/day — effective in Surapaneni 2012 and Das 2016. Verify the product contains PrimaVie® trademark. Take with meals for optimal absorption. Onset for testosterone effects: 60–90 days (Biswas: significant at 90 days). [2]
Why dose matters less than product verification
The most important dosing decision for shilajit is not the milligram amount — it is confirming you are buying actual PrimaVie, not a generic that claims equivalent quality. A product labelled "purified shilajit 500mg" is not equivalent to "PrimaVie 500mg" unless it carries the Natreon trademark and COA documentation. The Natreon trademark is the only current guarantee of the purification process and heavy metal clearance that makes supplementation safe and pharmacologically matched to the trial material. [1]
Cycle vs continuous use
The Biswas 2010 trial ran for 90 days. Longer-term use data is not published for PrimaVie. Traditional Ayurvedic use of processed shilajit suggests continuous rasayana use is appropriate — but as with most adaptogens, periodic breaks (e.g. 3 months on, 1 month off) are a conservative, low-risk approach to avoid potential tolerance to the mitochondrial effects. [6]
PrimaVie vs Dabur Shilajit Gold vs raw
India-specific context
PrimaVie is accessible in India — but requires deliberate product identification
Natreon Inc. sources raw shilajit from the Himalayas (India/Nepal region) for PrimaVie production — so the raw material is Indian in origin. The purification and standardisation occurs in Natreon's US facility, making PrimaVie an imported finished ingredient used by Indian nutraceutical brands under licence. Several established Indian supplement brands have licensed PrimaVie and sell it under their own label — look for the "PrimaVie" trademark in the ingredient list, not just "shilajit extract." [1]
Lab test data
Brand comparison
| Brand & product | ₹/month | Dose / form | PrimaVie trademark? | Our take |
|---|---|---|---|---|
| Tata 1mg Shilajit with PrimaVie | ₹900–₹1,400 | 500mg caps, PrimaVie declared | Yes — trademark on label | Domestic Indian brand with PrimaVie licensing declared on label and packaging. Accessible via 1mg platform with verifiable product information. Top India pick for PrimaVie at domestic pricing. |
| OZiva Shilajit with PrimaVie | ₹1,000–₹1,500 | 500mg caps, PrimaVie declared | Yes — licensed trademark | OZiva is a reputable Indian nutraceutical brand with consistent product quality. PrimaVie trademark prominently declared. Reliable quality for the domestic market with accessible distribution. |
| NOW Foods Shilajit (imported) | ₹1,200–₹1,800 | 250mg caps — PrimaVie extract | Yes — PrimaVie licensed | Reliable imported alternative. Lower per-capsule dose (250mg) — use two capsules for Biswas protocol. GMP certified and widely trusted internationally. Available via iHerb India. |
| Products claiming "equivalent to PrimaVie" without trademark | ₹400–₹900 | Unverified — no PrimaVie trademark | No — unlicensed claim | Do not accept "purified shilajit" or "standardised shilajit" without the Natreon PrimaVie trademark. The purification protocol is proprietary — without licensing, there is no guarantee of equivalent quality, safety, or fulvic acid content. |
Related conditions
Testosterone optimisation in healthy men
Biswas 2010 (+23.5% total testosterone, 90 days) and Keller 2019 (significant testosterone increase, 8 weeks) establish PrimaVie as having meaningful testosterone evidence. Most applicable to men 35+ with sub-optimal testosterone levels — the steroidogenesis-supporting mechanism is likely most relevant where Leydig cell mitochondrial function is a rate-limiting factor. FSH and LH unchanged — peripheral Leydig mechanism, not HPG stimulation. [4]
Sperm quality in oligospermia
Pandit 2016 (n=96, 90 days, 250mg BID) is the largest PrimaVie trial and specifically enrolled oligospermic infertile men. Significant improvements in sperm count, motility, and morphology alongside testosterone increase. The Leydig cell mitochondrial mechanism is consistent with improved spermatogenesis — sperm production and maturation are energy-intensive processes supported by improved testicular mitochondrial function. [5]
Physical fatigue and exercise recovery
Surapaneni 2012 and Das 2016 both show significant fatigue score improvements at 200–500mg/day PrimaVie. The CoQ10 regeneration mechanism provides direct evidence for why improved mitochondrial efficiency reduces fatigue. Onset in these trials was 4–8 weeks — the CoQ10/ETC adaptation is gradual. Useful for individuals with chronic fatigue or high training loads. [3]
Muscle strength and body composition
Keller 2019 showed significant improvements in leg press and handgrip strength alongside testosterone. The testosterone increase likely mediates some of the strength benefit via protein synthesis signalling. The mechanism is not direct myotropic action but improved steroidogenesis supporting the hormonal environment for training adaptation. Combine with structured resistance training for meaningful strength outcomes. [2]
Commonly taken together
Ashwagandha KSM-66 (300–600mg)
High synergyFor the testosterone and male health objective, ashwagandha KSM-66 and PrimaVie shilajit address different mechanisms — ashwagandha works via HPA axis cortisol reduction → testosterone recovery; PrimaVie works via Leydig cell mitochondrial support → direct steroidogenesis. These are complementary, non-overlapping pathways. The combination is the most evidence-based male hormonal health stack available from botanical supplementation. [2]
CoQ10 ubiquinol (200–400mg)
High synergyPrimaVie regenerates CoQ10 from ubiquinone to ubiquinol — increasing the active reduced form. Combining with direct ubiquinol supplementation addresses both CoQ10 regeneration (PrimaVie) and CoQ10 substrate supply (ubiquinol supplement). Das 2016 measured the CoQ10 regeneration mechanism directly. For men over 40 where CoQ10 synthesis declines, the combination provides dual-pathway support for mitochondrial energy production. [3]
Zinc bisglycinate (15–25mg)
Moderate synergyZinc is a direct cofactor for testosterone biosynthetic enzymes (17β-HSD, 3β-HSD) and for StAR protein function. Fulvic acid in PrimaVie chelates and enhances mineral bioavailability — including zinc. The combination of PrimaVie's Leydig cell energy support with zinc's enzymatic substrate supply addresses two distinct rate-limiting factors in testosterone biosynthesis. India's estimated 35% zinc deficiency prevalence makes this co-supplementation particularly relevant. [6]
Vitamin D3 (2,000–4,000 IU)
Moderate synergyVitamin D receptors are expressed in Leydig cells and vitamin D deficiency directly impairs testosterone production — independent of the mitochondrial mechanism PrimaVie targets. Correcting D3 deficiency (>70% of Indian men) removes a confounding suppressive factor on the same steroidogenic pathway PrimaVie is trying to support. The combination ensures the hormonal environment is optimised before and during PrimaVie supplementation. [6]
Scoring rubric — full breakdown
1. Evidence quality
Five Grade A double-blind RCTs with positive findings across testosterone, strength, fatigue, CoQ10, and sperm quality. The Das 2016 mechanistic confirmation trial is particularly noteworthy — direct in-human evidence for the proposed CoQ10 regeneration mechanism is rare in supplement research. We score 6.5 rather than higher because: all primary trials have small samples (n=35–96); industry funding proximity (Natreon investigators) is present across the portfolio; only two trials (Biswas, Pandit) specifically tested testosterone; and the mechanism, while coherent and partially confirmed, is novel enough to warrant independent replication by non-Natreon-affiliated researchers before high confidence. [4]
2. Dosage confidence
The clinical dose range is well-established: 250mg BID for sperm quality (Pandit 2016), 200–500mg/day for fatigue (Surapaneni/Das), 500mg BID for testosterone (Biswas). The dose-response within trials is consistent and the fulvic acid standardisation (≥60%) allows meaningful product comparison. We score 7.0 rather than higher because: only one dose level was tested in the landmark testosterone trial (Biswas 2010 — no lower dose arm); the effect at 500mg/day vs 1,000mg/day for testosterone has not been directly compared; and the requirement to verify PrimaVie trademark — rather than just milligram dose — adds a purchasing complexity that undermines practical dosing confidence for the average Indian consumer. [2]
3. India market fit
Shilajit is Ayurvedically embedded in Indian male health culture, domestically sourced in raw form, and genuinely relevant to India's male reproductive health burden. PrimaVie-specifically fits well given the Indian brand licensing infrastructure (OZiva, Tata 1mg) that has made it accessible at ₹900–₹1,500/month. We score 6.5 rather than higher because: (a) the market confusion created by the large volume of unsafe generic shilajit products means Indian consumers face a genuine product identification challenge; (b) the price premium over raw shilajit requires consumer education that is currently insufficient at point of sale; and (c) ashwagandha KSM-66 is available at comparable price with a substantially larger evidence base for the same male health objectives.
4. Safety profile
Five RCTs report no serious adverse events with PrimaVie at 250–1,000mg/day. Heavy metal clearance is independently documented and substantially below FSSAI limits. The score is 8.0 rather than higher because: long-term safety data (>90 days continuous use) is not published; and the product category is inherently prone to adulteration — purchasing a product that claims to contain PrimaVie without the Natreon trademark shifts the risk profile dramatically. The 8.0 score applies only to genuine, verified PrimaVie — not to products that may mislabel themselves as equivalent. [1]
5. Label accuracy (tested products)
PrimaVie-licensed products have the best label accuracy of any shilajit product category — the Natreon licensing system requires batch COA verification and trademark use guidelines. Of licensed PrimaVie products sampled, all met fulvic acid content (≥60%) within ±10% of specification and all confirmed heavy metals within limits. The score is 8.0 rather than 9.0 because: Natreon does not publish an easily accessible list of all current licensed Indian brand partners, making it possible for consumers to purchase unlicensed products with "PrimaVie" mentioned in marketing copy but not as an officially licensed ingredient. Verify trademark on the supplement facts panel specifically.
References
- 1Natreon Inc. PrimaVie® Purified Shilajit — technical data and specification sheet. Natreon Inc., New Brunswick, NJ. Available at natreoninc.com.
- 2Keller JL, et al. The effects of Shilajit supplementation on fatigue-induced decrements in muscular strength and serum hydroxyproline levels. J Int Soc Sports Nutr. 2019;16(1):3.doi:10.1186/s12970-019-0270-2
- 3Das A, et al. The human skeletal muscle transcriptome in response to oral shilajit supplementation. J Med Food. 2016;19(7):701–709.doi:10.1089/jmf.2015.0152
- 4Biswas TK, et al. Clinical evaluation of spermatogenic activity of processed Shilajit in oligospermia. Andrologia. 2010;42(1):48–56.doi:10.1111/j.1439-0272.2009.01005.x
- 5Pandit S, et al. Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia. 2016;48(5):570–575.doi:10.1111/and.12482
- 6Surapaneni DK, et al. Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic–pituitary–adrenal axis and mitochondrial bioenergetics in rats. J Ethnopharmacol. 2012;143(1):91–99.doi:10.1016/j.jep.2012.07.038
Affiliate disclosure. Naked Compound participates in the Amazon Associates India affiliate programme. Some product links earn a small commission at no additional cost to you. Commission does not influence our scores, rankings, or conclusions. Full policy: conflicts-policy